What is the 13F Pro Quality Score for LFWD?

13F Pro ranks Lifeward Ltd. (LFWD) on the 13F Pro Quality Score, a 0–100 composite of 32 fundamental signals including return on invested capital, free cash flow consistency, balance-sheet strength, earnings quality, growth durability, and valuation discipline. The score refreshes after each 10-K and 10-Q filing on SEC EDGAR. View LFWD's current score at https://13fpro.ai/research/LFWD (free sign-up required for the full ranking).

Where does 13F Pro source LFWD data?

All Lifeward Ltd. fundamentals and ownership data come directly from SEC EDGAR. Lifeward Ltd. files with the SEC under CIK 1607962. 13F Pro ingests XBRL financial facts from 10-K and 10-Q filings, Form 13F-HR institutional holdings, and Form 4 insider transactions, with no third-party rewrites or estimates.

What sector is LFWD in?

Lifeward Ltd. (LFWD) is classified in the Healthcare sector. 13F Pro publishes sector-level fund flow analysis and quality leaders at https://13fpro.ai/research/sector/healthcare.

How often is LFWD research updated on 13F Pro?

LFWD's fundamentals refresh within hours of each new 10-K or 10-Q filing on SEC EDGAR. Institutional ownership updates after each quarterly 13F filing window. Insider transactions update after each Form 4 filing. The 13F Pro Quality Score recalculates after every fundamentals refresh.

Lifeward Ltd.(LFWD)Stock Analysis

AI analysis on 2,800+ stocks →Deep AI analysis on 2,800+ stocks →

Healthcare →Nasdaq

Institutional-grade research for retail investors

SEC EDGAR: CIK 1607962 LFWD stock profile & AI dashboard →

13F Pro Quality Score

Not in ranked universe

Below size threshold

Quality rankings require at least $50M annual revenue or $250M total assets to filter out micro-caps and shell companies. This company reported $25.7M in revenue.

Financial data, filings, and institutional holdings below are still tracked in full — only the proprietary quality composite is unavailable for this name.

LFWD Stock Analysis & AI Quality Score

AI stock analysis and institutional research for Lifeward Ltd. (LFWD), a Healthcare sector company. LFWD is not currently included in 13F Pro's AI-ranked quality universe — quality rankings require at least $50m annual revenue or $250m total assets to filter out micro-caps and shell companies. this company reported $25.7m in revenue. Based on the latest XBRL financial filings (Q1 2026), Lifeward Ltd. reports quarterly revenue of $3.9M, net income of $-10.8M, free cash flow of $-3.7M. Top institutional holders of LFWD by reported 13-F value include RENAISSANCE TECHNOLOGIES, SUSQUEHANNA INTERNATIONAL GROUP, LLP, TWO SIGMA SECURITIES,, based on the most recent SEC filings. LFWD trades on the Nasdaq exchange and files with the SEC under CIK 1607962. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate LFWD daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Lifeward Ltd. directly from SEC EDGAR.

Revenue

Q1 2026

$3.9M

Net Income

Q1 2026

$-10.8M

Free Cash Flow

Q1 2026

$-3.7M

Revenue & Net Income

Earnings Per Share

Key Financials Over Time

Export Financial Table · Pro+

Revenue

-14.1% YoY

$22.0MFY 2025

FY21 $6.0MFY23 $13.9MFY24 $25.7MFY25 $22.0M

Net Income

+31.2% YoY

$-19.9MFY 2025

FY21 $-12.7MFY23 $-22.1MFY24 $-28.9MFY25 $-19.9M

Operating Income

+33.0% YoY

$-19.7MFY 2025

FY21 $-12.7MFY23 $-23.6MFY24 $-29.3MFY25 $-19.7M

EPS (Diluted)

+57.1% YoY

$-17.16FY 2025

FY21 $-0.27FY23 $-0.37FY24 $-39.96FY25 $-17.16

Total Assets

-24.9% YoY

$22.9MFY 2025

FY21 $94.8MFY23 $63.2MFY24 $30.5MFY25 $22.9M

Total Debt

—FY 2025

FY21 —FY23 —FY24 —FY25 —

Op. Cash Flow

+22.5% YoY

$-16.8MFY 2025

FY21 $-11.5MFY23 $-20.7MFY24 $-21.7MFY25 $-16.8M

Metric	FY 2025	FY 2024	FY 2023	FY 2021	FY 2019	FY 2018
Revenue	$22.0M -14.1%	$25.7M +85.2%	$13.9M +132.2%	$6.0M +22.4%	$4.9M -25.5%	$6.5M
Net Income	$-19.9M +31.2%	$-28.9M -30.8%	$-22.1M -73.8%	$-12.7M +18.1%	$-15.6M +28.3%	$-21.7M
Operating Income	$-19.7M +33.0%	$-29.3M -24.3%	$-23.6M -86.6%	$-12.7M +9.9%	$-14.0M +26.9%	$-19.2M
EPS (Diluted)	$-17.16 +57.1%	$-39.96 -10700.0%	$-0.37 -37.0%	$-0.27	—	—
Total Assets	$22.9M -24.9%	$30.5M -51.8%	$63.2M -33.3%	$94.8M +288.8%	$24.4M +62.9%	$15.0M
Total Debt	—	—	—	—	$7.0M -19.8%	$8.7M
Operating Cash Flow	$-16.8M +22.5%	$-21.7M -5.1%	$-20.7M -80.2%	$-11.5M +22.6%	$-14.8M -0.3%	$-14.8M

AI Insight: LFWD Financial Trends

Lifeward is burning through equity with no path to profitability: revenue down 43% from Q2 2024 to Q1 2026 while equity shrunk 84% to $6M.

• Revenue collapsed from $7M in Q2 2024 to $4M in Q1 2026, a 43% decline over eight quarters.

• Operating cash flow remained persistently negative at $4M per quarter throughout 2025 and Q1 2026.

• Equity eroded from $37M in Q2 2024 to $6M in Q1 2026, a loss of $31M or 84% of original base.

⚠ Net loss spiked to $11M in Q1 2026, worst result since Q4 2024's $15M loss, despite flat operating CF.

⚠ Equity now $6M with no debt disclosed — runway limited if burn rate persists at $4M–$5M quarterly.

AI Insight: LFWD Ratio Trends

Lifeward remains deeply unprofitable with operating margin collapsing to -120.2% on TTM basis; no path to profitability visible.

• Operating margin deteriorated from -51.8% in Q3 2024 to -120.2% TTM, driven by persistent operating losses and revenue decline.

• ROA fell from -27.0% in Q3 2024 to -77.4% TTM; negative asset returns have worsened significantly over the last 18 months.

• Q3 2025 showed temporary improvement with OpMargin at -50.7%, but TTM aggregate masks ongoing operational stress and cash burn.

⚠ No leverage or debt/equity data reported—capital structure and liquidity position remain opaque; critical to assess runway.

⚠ Consistent negative ROIC and ROE suggest value destruction; equity holders absorbing cumulative losses without evidence of turnaround.

⚠ Q1 2026 data gaps suggest reporting discontinuity or operational disruption; monitor next earnings release closely for viability.

Get alerted when LFWD's score changes

Free account: watchlist tracking, the daily AI brief, and the AI screener.

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Available Research

13F Pro tracks comprehensive data for Lifeward Ltd. including:

SEC EDGAR filings (10-K, 10-Q, 8-K)

XBRL financial facts (revenue, EPS, margins)

Insider transactions (Form 4)

Institutional 13F holdings

Quality rankings (32 signals)

AI analyst debates & daily meetings

Historical financial trends

Peer comparison & sector analysis

Top Institutional Holders of LFWD

RENAISSANCE TECHNOLOGIES LLC
$74.8K129,706 sh
SUSQUEHANNA INTERNATIONAL GROUP, LLP
$47.6K82,620 sh
TWO SIGMA SECURITIES, LLC
$46.7K81,029 sh
JANE STREET GROUP, LLC
$39.6K68,631 sh
BANK OF AMERICA CORP /DE/
$36.8K63,832 sh
LPL Financial LLC
$19.7K34,236 sh
XTX Topco Ltd
$17.6K30,445 sh
Robertson Stephens Wealth Management, LLC
$17.1K29,700 sh
UBS Group AG
$11.0K19,084 sh
Robertson Stephens Wealth Management, LLC
$6.2K10,800 sh

Fund	Value	Shares
RENAISSANCE TECHNOLOGIES LLC	$74.8K	129,706
SUSQUEHANNA INTERNATIONAL GROUP, LLP	$47.6K	82,620
TWO SIGMA SECURITIES, LLC	$46.7K	81,029
JANE STREET GROUP, LLC	$39.6K	68,631
BANK OF AMERICA CORP /DE/	$36.8K	63,832
LPL Financial LLC	$19.7K	34,236
XTX Topco Ltd	$17.6K	30,445
Robertson Stephens Wealth Management, LLC	$17.1K	29,700
UBS Group AG	$11.0K	19,084
Robertson Stephens Wealth Management, LLC	$6.2K	10,800

More Healthcare Companies

View all Healthcare →

AAPG

ASCENTAGE PHARMA GROUP INTERNATIONAL

AARD

Aardvark Therapeutics, Inc.

ABBV

AbbVie Inc.

ABCL

AbCellera Biologics Inc.

ABEO

ABEONA THERAPEUTICS INC.

ABOS

Acumen Pharmaceuticals, Inc.

ABPWW

Abpro Holdings, Inc.

ABSI

Absci Corp

Put LFWD on your watchlist

Track score changes the day Lifeward Ltd. files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.

View Pricing

Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Popular Research

AAPL

Apple

MSFT

Microsoft

NVDA

NVIDIA

GOOG

Alphabet

AMZN

Amazon

Is LFWD a good stock to buy?

13F Pro's AI-powered analysis of Lifeward Ltd. (LFWD) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Healthcare sector (listed on Nasdaq). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for LFWD are available on the LFWD stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing.

Which hedge funds own LFWD?

Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling LFWD. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of Lifeward Ltd.'s investment landscape.